Engineering the tumor microenvironment: oncolytic NDV to facilitate CAR-T cell therapy
Abstract Chimeric antigen receptor (CAR)-T cell therapy has achieved significant progress in the treatment of hematologic cancers but continues to face major obstacles in solid tumors, including antigen heterogeneity, limited infiltration, and an immunosuppressive tumor microenvironment (TME). Oncol...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2025-11-01
|
| Saila: | Journal of Translational Medicine |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12967-025-07342-0 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|